Xu X - Search Results

1

HSP70 regulates cell proliferation and apoptosis in actinomycin-D-treated lung cancer cells.

Zhang K, Zhai R, Xue T, Xu X, Ren Y, Ma M, Shi F, Wang H, Wang N, Zhou F. Zhang K, et al. Among authors: xu x. Transl Cancer Res. 2020 Feb;9(2):1167-1173. doi: 10.21037/tcr.2019.12.100. Transl Cancer Res. 2020. PMID: 35117461 Free PMC article.

2

[Role of nicotinamide vadenine dinucleotide phosphate oxidase 4 in transforming growth factor-β-induced A549 cell migration].

Xue T, Xu X, Xia Y, Ren Y, Zhou F. Xue T, et al. Among authors: xu x. Wei Sheng Yan Jiu. 2017 Jul;46(4):615-620. Wei Sheng Yan Jiu. 2017. PMID: 29903185 Chinese.

3

Construction of a 14-lncRNA risk score system predicting survival of children with acute myelocytic leukemia.

Guo S, Li B, Xu X, Wang W, Wang S, Lv T, Wang H. Guo S, et al. Among authors: xu x. Exp Ther Med. 2020 Aug;20(2):1521-1531. doi: 10.3892/etm.2020.8846. Epub 2020 Jun 5. Exp Ther Med. 2020. PMID: 32742384 Free PMC article.

4

Co-immunizing with PD-L1 induces CD8⁺ DCs-mediated anti-tumor immunity in multiple myeloma.

Guo S, Xiao P, Li B, Wang W, Wang S, Lv T, Xu X, Chen C, Huang L, Li Z, Tang L, Peng L, Wang H. Guo S, et al. Among authors: xu x. Int Immunopharmacol. 2020 Jul;84:106516. doi: 10.1016/j.intimp.2020.106516. Epub 2020 Apr 22. Int Immunopharmacol. 2020. PMID: 32334387

5

Elucidating the mechanism of stigmasterol in acute pancreatitis treatment: insights from network pharmacology and in vitro/in vivo experiments.

Zhao X, Li F, Wen A, Yu X, Xu X, Wan C, Cao Y, Xin G, Huang W. Zhao X, et al. Among authors: xu x. Front Pharmacol. 2024 Dec 23;15:1485915. doi: 10.3389/fphar.2024.1485915. eCollection 2024. Front Pharmacol. 2024. PMID: 39764471 Free PMC article.

6

Carrier-Free, Hyaluronic Acid-Modified Self-Assembled Doxorubicin, and Chlorin e6 Nanoparticles Enhance Combined Chemo- and Photodynamic Therapy in vivo.

Lin B, Lin P, Zhang X, Liao Y, Yu Y, Xu X, Wang X. Lin B, et al. Among authors: xu x. Int J Nanomedicine. 2024 Dec 31;19:14105-14124. doi: 10.2147/IJN.S490485. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39764187 Free PMC article.

7

Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia.

Akif A, Nguyen TTM, Liu L, Xu X, Kulkarni A, Jiang J, Zhang Y, Hao J. Akif A, et al. Among authors: xu x. Res Sq [Preprint]. 2024 Dec 20:rs.3.rs-5611378. doi: 10.21203/rs.3.rs-5611378/v1. Res Sq. 2024. PMID: 39764140 Free PMC article. Preprint.

8

CDH3-AS1 antisense RNA enhances P-cadherin translation and acts as a tumor suppressor in melanoma.

Chadourne M, Griffith C, Xu X, Brennan E, Vera O, Mecozzi N, Wang K, Jaeger AM, Karreth FA. Chadourne M, et al. Among authors: xu x. bioRxiv [Preprint]. 2024 Dec 26:2024.12.26.630428. doi: 10.1101/2024.12.26.630428. bioRxiv. 2024. PMID: 39764055 Free PMC article. Preprint.

9

Efficacy and safety of chimeric antigen receptor T cells targeting BCMA and GPRC5D in relapsed or refractory multiple myeloma.

Yang X, Wang F, Yuan X, Yang B, Chen J, Cheng J, Liu G, Tang D, Xu X, Wang S, He Z, Liu Y, Li Y. Yang X, et al. Among authors: xu x. Front Immunol. 2024 Dec 23;15:1466443. doi: 10.3389/fimmu.2024.1466443. eCollection 2024. Front Immunol. 2024. PMID: 39763668 Free PMC article.

10

Penpulimab and Anlotinib in PDL1 high-expression pulmonary giant cell carcinoma with cerebral metastases: case report and review.

Xie M, Zhao Y, Hou X, Li N, Niu S, Xu X. Xie M, et al. Among authors: xu x. Front Oncol. 2024 Dec 23;14:1476205. doi: 10.3389/fonc.2024.1476205. eCollection 2024. Front Oncol. 2024. PMID: 39763602 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58,092 results

Search Page

Filters